Tomio Jinnouchi
Jinnouchi, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 30 publications
High Frequency of Defecation under Metformin Use May Be a Potential Glucose-lowering Factor Independent of the Dose-dependent Effect of Metformin in Patients with Type 2 Diabetes Mellitus.
Journal: Internal medicine (Tokyo, Japan)
Published: October 27, 2024
Reduced Number of Remaining or Healthy Teeth in Patients with Type 2 Diabetes Mellitus: A Cross-sectional Study Assessed by Dentists or Dental Hygienists in Japan.
Journal: Internal medicine (Tokyo, Japan)
Published: April 02, 2023
Potential Identification of Type 2 Diabetes with Elevated Insulin Clearance.
Journal: NEJM evidence
Published: April 01, 2022
Changes in urinary glucose concentration and body weight in patients treated with the selective SGLT2 inhibitor luseogliflozin.
Journal: Diabetes research and clinical practice
Published: December 13, 2020
Body Muscle-to-Fat Ratio, Rather Than Fat-to-Muscle Ratio, Significantly Correlates With Measured Insulin Resistance in Patients With Type 2 Diabetes Mellitus.
Journal: Journal of clinical medicine research
Published: December 01, 2020
Initial Acute Decline in Estimated Glomerular Filtration Rate After Sodium-Glucose Cotransporter-2 Inhibitor in Patients With Chronic Kidney Disease.
Journal: Journal of clinical medicine research
Published: September 16, 2020
Characteristics of nephropathy in severely obese Japanese patients complicated with type 2 diabetes mellitus: a cross-sectional cohort study.
Journal: Endocrine
Published: November 22, 2019
Elevation of the renal threshold for glucose is associated with insulin resistance and higher glycated hemoglobin levels.
Journal: Journal of diabetes investigation
Published: August 21, 2019
Body muscle-to-fat ratio gender-specific cut-off values for impaired insulin sensitivity in patients with treatment-naïve type 2 diabetes mellitus.
Journal: Endocrine
Published: May 23, 2019
Renoprotective Effects of Additional SGLT2 inhibitor Therapy in Patients With Type 2 Diabetes Mellitus and Chronic Kidney Disease Stages 3b-4: A Real World Report From A Japanese Specialized Diabetes Care Center.
Journal: Journal of clinical medicine research
Published: January 21, 2019
Clinical usefulness of the body muscle-to-fat ratio for screening obstructive sleep apnea syndrome in patients with inadequately controlled type 2 diabetes mellitus.
Journal: Diabetes research and clinical practice
Published: April 14, 2018
The SGLT2 Inhibitor Dapagliflozin Significantly Improves the Peripheral Microvascular Endothelial Function in Patients with Uncontrolled Type 2 Diabetes Mellitus.
Journal: Internal medicine (Tokyo, Japan)
Published: April 03, 2018
Last Updated: 09/26/2026